Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Alternative option labeling impacts decision-making in noninvasive prenatal screening.

Fisher CF, Birkeland LE, Reiser CA, Zhao Q, Palmer CGS, Zikmund-Fisher BJ, Petty EM.

J Genet Couns. 2019 Dec 3. doi: 10.1002/jgc4.1191. [Epub ahead of print]

PMID:
31793699
2.

Genetic counselor workforce generational diversity: Millennials to Baby Boomers.

Reiser C, Van Vreede V, Petty EM.

J Genet Couns. 2019 Aug;28(4):730-737. doi: 10.1002/jgc4.1107. Epub 2019 Mar 2.

PMID:
30825359
3.

Perceived Changes to Obstetric Care and the Integration of Personal and Professional Life as a Pregnant Prenatal Genetic Counselor.

Rietzler JL, Birkeland LE, Petty EM.

J Genet Couns. 2018 Aug;27(4):978-987. doi: 10.1007/s10897-018-0210-3. Epub 2018 Feb 8.

PMID:
29423570
4.

Working with the Hmong Population in a Genetics Setting: an Interpreter Perspective.

Krieger M, Agather A, Douglass K, Reiser CA, Petty EM.

J Genet Couns. 2018 Jun;27(3):565-573. doi: 10.1007/s10897-017-0153-0. Epub 2017 Sep 24.

PMID:
28942494
5.

Counseling Close to Home: Genetic Counselors' Experiences with their own Family Members.

Rust L, Adamsheck H, Reiser CA, Petty EM.

J Genet Couns. 2018 Feb;27(1):225-240. doi: 10.1007/s10897-017-0138-z. Epub 2017 Aug 16.

PMID:
28815348
6.

Is Low FMR1 CGG Repeat Length in Males Correlated with Family History of BRCA-Associated Cancers? An Exploratory Analysis of Medical Records.

Adamsheck HC, Petty EM, Hong J, Baker MW, Brilliant MH, Mailick MR.

J Genet Couns. 2017 Dec;26(6):1401-1410. doi: 10.1007/s10897-017-0116-5. Epub 2017 Jun 30.

PMID:
28667565
7.

Working with the Hmong Population in a Genetics Setting: Genetic Counselor Perspectives.

Agather A, Rietzler J, Reiser CA, Petty EM.

J Genet Couns. 2017 Dec;26(6):1388-1400. doi: 10.1007/s10897-017-0117-4. Epub 2017 Jun 28.

PMID:
28660354
8.

Science of health care delivery as a first step to advance undergraduate medical education: A multi-institutional collaboration.

Starr SR, Reed DA, Essary A, Hueston W, Johnson CD, Landman N, Meurer J, Miller B, Ogrinc G, Petty EM, Raymond J, Riley W, Gabriel S, Maurana C.

Healthc (Amst). 2017 Sep;5(3):98-104. doi: 10.1016/j.hjdsi.2017.01.003. Epub 2017 Mar 23.

PMID:
28342917
9.

2013 Review and Update of the Genetic Counseling Practice Based Competencies by a Task Force of the Accreditation Council for Genetic Counseling.

Doyle DL, Awwad RI, Austin JC, Baty BJ, Bergner AL, Brewster SJ, Erby LA, Franklin CR, Greb AE, Grubs RE, Hooker GW, Noblin SJ, Ormond KE, Palmer CG, Petty EM, Singletary CN, Thomas MJ, Toriello H, Walton CS, Uhlmann WR.

J Genet Couns. 2016 Oct;25(5):868-79. doi: 10.1007/s10897-016-9984-3. Epub 2016 Jun 23.

10.

An AXIN2 Mutant Allele Associated With Predisposition to Colorectal Neoplasia Has Context-Dependent Effects on AXIN2 Protein Function.

Mazzoni SM, Petty EM, Stoffel EM, Fearon ER.

Neoplasia. 2015 May;17(5):463-72. doi: 10.1016/j.neo.2015.04.006.

11.

Anticipated motivation for genetic testing among smokers, nonsmokers, and former smokers: an exploratory qualitative study of decision making.

Giordimaina AM, Sheldon JP, Petty EM.

Public Health Genomics. 2014;17(4):228-39. doi: 10.1159/000364803. Epub 2014 Jul 19.

PMID:
25059656
12.

Genetic counseling graduate student debt: impact on program, career and life choices.

Kuhl A, Reiser C, Eickhoff J, Petty EM.

J Genet Couns. 2014 Oct;23(5):824-37. doi: 10.1007/s10897-014-9700-0. Epub 2014 Mar 1.

13.

What is appropriate to post on social media? Ratings from students, faculty members and the public.

Jain A, Petty EM, Jaber RM, Tackett S, Purkiss J, Fitzgerald J, White C.

Med Educ. 2014 Feb;48(2):157-69. doi: 10.1111/medu.12282.

14.

Ehlers-Danlos syndrome, hypermobility type: A characterization of the patients' lived experience.

Murray B, Yashar BM, Uhlmann WR, Clauw DJ, Petty EM.

Am J Med Genet A. 2013 Dec;161A(12):2981-8. doi: 10.1002/ajmg.a.36293. Epub 2013 Nov 6.

PMID:
24254846
15.

Quality of life and autonomy in emerging adults with early-onset neuromuscular disorders.

Huismann DJ, Sheldon JP, Yashar BM, Amburgey K, Dowling JJ, Petty EM.

J Genet Couns. 2012 Oct;21(5):713-25. doi: 10.1007/s10897-012-9492-z. Epub 2012 Feb 25.

16.
17.

SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.

Peterson EA, Stanbery L, Li C, Kocak H, Makarova O, Petty EM.

Genes Chromosomes Cancer. 2011 Nov;50(11):940-9. doi: 10.1002/gcc.20916. Epub 2011 Aug 24.

18.

CHFR binds to and regulates MAD2 in the spindle checkpoint through its cysteine-rich domain.

Keller JA, Petty EM.

Biochem Biophys Res Commun. 2011 Jun 10;409(3):389-93. doi: 10.1016/j.bbrc.2011.04.143. Epub 2011 May 7.

19.
20.

AXIN2-associated autosomal dominant ectodermal dysplasia and neoplastic syndrome.

Marvin ML, Mazzoni SM, Herron CM, Edwards S, Gruber SB, Petty EM.

Am J Med Genet A. 2011 Apr;155A(4):898-902. doi: 10.1002/ajmg.a.33927. Epub 2011 Mar 17.

21.

Connections between CHFR, the cell cycle, and chemosensitivity: Are they critical in cancer?

Keller JA, Erson-Bensan AE, Petty EM.

Cancer Biol Ther. 2010 Nov 1;10(9):942-4. doi: 10.4161/cbt.10.9.13876. Epub 2010 Nov 1. No abstract available.

PMID:
21057211
22.

High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma.

Stanbery L, D'Silva NJ, Lee JS, Bradford CR, Carey TE, Prince ME, Wolf GT, Worden FP, Cordell KG, Petty EM.

Transl Oncol. 2010 Aug 1;3(4):239-45.

23.

USP32 is an active, membrane-bound ubiquitin protease overexpressed in breast cancers.

Akhavantabasi S, Akman HB, Sapmaz A, Keller J, Petty EM, Erson AE.

Mamm Genome. 2010 Aug;21(7-8):388-97. doi: 10.1007/s00335-010-9268-4. Epub 2010 Jun 13.

PMID:
20549504
24.

Conquering the complex world of human septins: implications for health and disease.

Peterson EA, Petty EM.

Clin Genet. 2010 Jun;77(6):511-24. doi: 10.1111/j.1399-0004.2010.01392.x. Epub 2010 Feb 11. Review.

25.

Understandings of basic genetics in the United States: results from a national survey of black and white men and women.

Christensen KD, Jayaratne TE, Roberts JS, Kardia SL, Petty EM.

Public Health Genomics. 2010;13(7-8):467-76. doi: 10.1159/000293287. Epub 2010 Mar 5.

26.

miRNAs and cancer: New research developments and potential clinical applications.

Erson AE, Petty EM.

Cancer Biol Ther. 2009 Dec;8(24):2317-22. Epub 2009 Dec 30. Review.

PMID:
20168083
27.

The Perennial Debate: Nature, Nurture, or Choice? Black and White Americans' Explanations for Individual Differences.

Jayaratne TE, Gelman SA, Feldbaum M, Sheldon JP, Petty EM, Kardia SL.

Rev Gen Psychol. 2009 Mar 1;13(1):24-33.

28.

Petty-Laxova-Wiedemann progeroid syndrome: further phenotypical delineation and confirmation of a rare syndrome of premature aging.

Delgado-Luengo WN, Petty EM, Solís-Añez E, Römel O, Delgado-Luengo J, Hernández ML, Morales-Machín A, Borjas-Fuentes L, Zabala-Fernández W, González-Ferrer S, Pineda-Bernal L, Pardo-Govea T, Martínez-Basalo MC, González R, Urdaneta K, Cañizales J, Fleitas-Cabello H.

Am J Med Genet A. 2009 Oct;149A(10):2200-5. doi: 10.1002/ajmg.a.32884.

PMID:
19725131
29.

Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy.

Landsverk ML, Ruzzo EK, Mefford HC, Buysse K, Buchan JG, Eichler EE, Petty EM, Peterson EA, Knutzen DM, Barnett K, Farlow MR, Caress J, Parry GJ, Quan D, Gardner KL, Hong M, Simmons Z, Bird TD, Chance PF, Hannibal MC.

Hum Mol Genet. 2009 Apr 1;18(7):1200-8. doi: 10.1093/hmg/ddp014. Epub 2009 Jan 12.

30.

Up-regulation of SEPT9_v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells.

Gonzalez ME, Makarova O, Peterson EA, Privette LM, Petty EM.

Cell Signal. 2009 Apr;21(4):477-87. doi: 10.1016/j.cellsig.2008.11.007. Epub 2008 Nov 18.

31.

MicroRNAs in development and disease.

Erson AE, Petty EM.

Clin Genet. 2008 Oct;74(4):296-306. doi: 10.1111/j.1399-0004.2008.01076.x. Epub 2008 Aug 18. Review.

PMID:
18713256
32.

CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

Privette LM, Petty EM.

Transl Oncol. 2008 Jul;1(2):57-64.

33.
34.

The role of steroid hormones in the NF1 phenotype: focus on pregnancy.

Roth TM, Petty EM, Barald KF.

Am J Med Genet A. 2008 Jun 15;146A(12):1624-33. doi: 10.1002/ajmg.a.32301. Review.

35.

Airway obstruction caused by PTEN hamartoma (Bannayan-Riley-Ruvalcaba) syndrome.

Sharma MR, Petty EM, Lesperance MM.

Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1157-60. No abstract available.

PMID:
18025323
36.

Characterization of a SEPT9 interacting protein, SEPT14, a novel testis-specific septin.

Peterson EA, Kalikin LM, Steels JD, Estey MP, Trimble WS, Petty EM.

Mamm Genome. 2007 Nov;18(11):796-807. Epub 2007 Oct 6.

PMID:
17922164
37.

High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes.

Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM, Petty EM.

Cancer Res. 2007 Sep 15;67(18):8554-64.

38.

Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression.

Privette LM, González ME, Ding L, Kleer CG, Petty EM.

Cancer Res. 2007 Jul 1;67(13):6064-74. Epub 2007 Jun 27.

39.

Beliefs about the etiology of homosexuality and about the ramifications of discovering its possible genetic origin.

Sheldon JP, Pfeffer CA, Jayaratne TE, Feldbaum M, Petty EM.

J Homosex. 2007;52(3-4):111-50.

40.

Applications and implications of advances in human genetics: perspectives from a group of Black Americans.

Sheldon JP, Epstein Jayaratne T, Feldbaum MB, DiNardo CD, Petty EM.

Community Genet. 2007;10(2):82-92.

PMID:
17380057
41.

White Americans' Genetic Lay Theories of Race Differences and Sexual Orientation: Their Relationship with Prejudice toward Blacks, and Gay Men and Lesbians.

Jayaratne TE, Ybarra O, Sheldon JP, Brown TN, Feldbaum M, Pfeffer C, Petty EM.

Group Process Intergroup Relat. 2006 Jan;9(1). doi: 10.1177/1368430206059863.

42.

Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation.

Chao MM, Levine JE, Ruiz RE, Kohlmann WK, Bower MA, Petty EM, Mody RJ.

Pediatr Blood Cancer. 2007 Dec;49(7):1000-4.

PMID:
16333835
43.

Skewed X-inactivation in carriers establishes linkage in an X-linked deafness-mental retardation syndrome.

Probst FJ, Hedera P, Sclafani AM, Pomponi MG, Neri G, Tyson J, Douglas JA, Petty EM, Martin DM.

Am J Med Genet A. 2004 Dec 1;131(2):209-12. No abstract available. Erratum in: Am J Med Genet A. 2005 Apr 30;134(3):347.

PMID:
15389700
44.

Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1).

Meredith C, Herrmann R, Parry C, Liyanage K, Dye DE, Durling HJ, Duff RM, Beckman K, de Visser M, van der Graaff MM, Hedera P, Fink JK, Petty EM, Lamont P, Fabian V, Bridges L, Voit T, Mastaglia FL, Laing NG.

Am J Hum Genet. 2004 Oct;75(4):703-8. Epub 2004 Aug 20.

45.

Exploring the public understanding of basic genetic concepts.

Lanie AD, Jayaratne TE, Sheldon JP, Kardia SL, Anderson ES, Feldbaum M, Petty EM.

J Genet Couns. 2004 Aug;13(4):305-20.

46.

CHFR-associated early G2/M checkpoint defects in breast cancer cells.

Erson AE, Petty EM.

Mol Carcinog. 2004 Jan;39(1):26-33.

47.

The second kindred with autosomal dominant distal myopathy linked to chromosome 14q: genetic and clinical analysis.

Hedera P, Petty EM, Bui MR, Blaivas M, Fink JK.

Arch Neurol. 2003 Sep;60(9):1321-5.

PMID:
12975303
48.

Characterization of a stapes ankylosis family with a NOG mutation.

Brown DJ, Kim TB, Petty EM, Downs CA, Martin DM, Strouse PJ, Moroi SE, Gebarski SS, Lesperance MM.

Otol Neurotol. 2003 Mar;24(2):210-5.

PMID:
12621334
49.

Mammalian septins nomenclature.

Macara IG, Baldarelli R, Field CM, Glotzer M, Hayashi Y, Hsu SC, Kennedy MB, Kinoshita M, Longtine M, Low C, Maltais LJ, McKenzie L, Mitchison TJ, Nishikawa T, Noda M, Petty EM, Peifer M, Pringle JR, Robinson PJ, Roth D, Russell SE, Stuhlmann H, Tanaka M, Tanaka T, Trimble WS, Ware J, Zeleznik-Le NJ, Zieger B.

Mol Biol Cell. 2002 Dec;13(12):4111-3.

50.

Mutant deoxynucleotide carrier is associated with congenital microcephaly.

Rosenberg MJ, Agarwala R, Bouffard G, Davis J, Fiermonte G, Hilliard MS, Koch T, Kalikin LM, Makalowska I, Morton DH, Petty EM, Weber JL, Palmieri F, Kelley RI, Schäffer AA, Biesecker LG.

Nat Genet. 2002 Sep;32(1):175-9. Epub 2002 Aug 19.

PMID:
12185364

Supplemental Content

Loading ...
Support Center